Paragon Capital Management LLC purchased a new position in shares of CannTrust Holdings Inc (NYSE:CTST) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,000 shares of the company’s stock, valued at approximately $54,000.

Several other hedge funds have also modified their holdings of the company. Virtu Financial LLC acquired a new position in CannTrust during the first quarter worth $618,000. Legacy Advisors LLC acquired a new position in CannTrust during the first quarter worth $1,555,000. Finally, Davis Rea LTD. bought a new stake in shares of CannTrust during the first quarter worth $3,846,000. Institutional investors own 0.08% of the company’s stock.

Several brokerages have recently commented on CTST. Bloom Burton restated an “accumulate” rating on shares of CannTrust in a report on Friday, March 29th. Zacks Investment Research upgraded CannTrust from a “hold” rating to a “buy” rating and set a $9.00 target price on the stock in a report on Tuesday, April 2nd.

Shares of CTST stock traded down C$0.30 during trading hours on Monday, hitting C$6.87. 1,388,522 shares of the company’s stock were exchanged, compared to its average volume of 1,167,752. The company has a debt-to-equity ratio of 0.06, a quick ratio of 5.54 and a current ratio of 7.65. The stock has a market capitalization of $729.97 million, a PE ratio of -62.45 and a beta of 4.40. CannTrust Holdings Inc has a 52 week low of C$4.35 and a 52 week high of C$11.97.

CannTrust (NYSE:CTST) last announced its earnings results on Thursday, March 28th. The company reported C($0.20) EPS for the quarter, missing the consensus estimate of C($0.04) by C($0.16). The business had revenue of C$16.20 million for the quarter, compared to the consensus estimate of C$20.99 million. CannTrust had a negative return on equity of 7.34% and a negative net margin of 28.09%. The business’s revenue was up 131.4% compared to the same quarter last year. As a group, analysts forecast that CannTrust Holdings Inc will post 0.03 earnings per share for the current fiscal year.

WARNING: This report was first posted by Daily Political and is owned by of Daily Political. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at

CannTrust Company Profile

CannTrust Holdings Inc produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner. The company has a partnership with Gold Coast University Hospital.

Read More: Put Option

Want to see what other hedge funds are holding CTST? Visit to get the latest 13F filings and insider trades for CannTrust Holdings Inc (NYSE:CTST).

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with's FREE daily email newsletter.